These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28416267)

  • 1. Molecular Mechanisms and Targets of Therapy for Hepatocellular Carcinoma.
    Klungboonkrong V; Das D; McLennan G
    J Vasc Interv Radiol; 2017 Jul; 28(7):949-955. PubMed ID: 28416267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic therapies for hepatocellular carcinoma.
    Ge S; Huang D
    Drug Discov Ther; 2015 Oct; 9(5):352-62. PubMed ID: 26632544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy.
    Tahmasebi Birgani M; Carloni V
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of hepatocellular carcinoma and molecular therapies.
    Mínguez B; Tovar V; Chiang D; Villanueva A; Llovet JM
    Curr Opin Gastroenterol; 2009 May; 25(3):186-94. PubMed ID: 19387255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic therapies in hepatocellular carcinoma: present and future.
    Bertino G; Di Carlo I; Ardiri A; Calvagno GS; Demma S; Malaguarnera G; Bertino N; Malaguarnera M; Toro A; Malaguarnera M
    Future Oncol; 2013 Oct; 9(10):1533-48. PubMed ID: 24106903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy for hepatocellular carcinoma: current situation and prospect.
    Wang Z; Zhang G; Wu J; Jia M
    Drug Discov Ther; 2013 Aug; 7(4):137-43. PubMed ID: 24071575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma: systemic therapies and future perspectives.
    Mikhail S; Cosgrove D; Zeidan A
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1205-18. PubMed ID: 25199765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular Carcinoma: Review of Targeted and Immune Therapies.
    da Motta Girardi D; Correa TS; Crosara Teixeira M; Dos Santos Fernandes G
    J Gastrointest Cancer; 2018 Sep; 49(3):227-236. PubMed ID: 29806062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations in hepatocellular carcinoma: An update.
    Niu ZS; Niu XJ; Wang WH
    World J Gastroenterol; 2016 Nov; 22(41):9069-9095. PubMed ID: 27895396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and molecular mechanisms of hepatocellular carcinoma: an update.
    Aravalli RN; Cressman EN; Steer CJ
    Arch Toxicol; 2013 Feb; 87(2):227-47. PubMed ID: 23007558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of hepatocellular carcinoma contributes to cancer progression.
    Jeng KS; Chang CF; Jeng WJ; Sheen IS; Jeng CJ
    Crit Rev Oncol Hematol; 2015 Jun; 94(3):337-47. PubMed ID: 25680939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging assessment of hepatocellular carcinoma response to locoregional and systemic therapy.
    Yaghmai V; Besa C; Kim E; Gatlin JL; Siddiqui NA; Taouli B
    AJR Am J Roentgenol; 2013 Jul; 201(1):80-96. PubMed ID: 23789661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma.
    DeLeon TT; Ahn DH; Bogenberger JM; Anastasiadis PZ; Arora M; Ramanathan RK; Aqel BA; Vasmatzis G; Truty MJ; Oklu R; Bekaii-Saab TS; Borad MJ
    Future Oncol; 2018 Mar; 14(6):553-566. PubMed ID: 29460642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Established and emerging therapies for hepatocellular carcinoma.
    Cicinnati VR; Sotiropoulos GC; Beckebaum S
    Minerva Med; 2010 Dec; 101(6):405-18. PubMed ID: 21196900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers.
    Wang Y; Deng B
    Cancer Metastasis Rev; 2023 Sep; 42(3):629-652. PubMed ID: 36729264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted therapy of hepatocellular cancer.
    Wysocki PJ
    Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel therapeutic strategies for treatment of hepatocellular carcinoma: targeting intervention on liver cancer stem cells].
    Li X; Luo Q; Song G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):894-8. PubMed ID: 24059077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the microenvironment in hepatocellular carcinoma development and progression.
    Wu SD; Ma YS; Fang Y; Liu LL; Fu D; Shen XZ
    Cancer Treat Rev; 2012 May; 38(3):218-25. PubMed ID: 21763074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.
    Pez F; Lopez A; Kim M; Wands JR; Caron de Fromentel C; Merle P
    J Hepatol; 2013 Nov; 59(5):1107-17. PubMed ID: 23835194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathogenesis of hepatocellular carcinoma.
    McKillop IH; Moran DM; Jin X; Koniaris LG
    J Surg Res; 2006 Nov; 136(1):125-35. PubMed ID: 17023002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.